SPY311.36-0.82 -0.26%
DIA263.33+0.16 0.06%
IXIC9,615.81-67.10 -0.69%
News
APVO
--
0.00%
--
Aptevo Therapeutics Reports First Quarter 2020 Financial Results
ACCESSWIRE · 05/13 14:00
78 Biggest Movers From Yesterday
Gainers
Benzinga · 05/12 09:02
54 Stocks Moving In Monday's Mid-Day Session
Gainers
Benzinga · 05/11 16:39
Stocks That Hit 52-Week Highs On Monday
Monday's morning session saw 70 companies set new 52-week highs.
Benzinga · 05/11 14:29
96 Biggest Movers From Friday
Gainers Fuel Tech, Inc (NASDAQ: FTEK) shares climbed 93.6% to close at $0.91 on Friday after the company reported FUEL CHEM® demonstration orders from two new industrial power customers.
Benzinga · 05/11 09:14
Stocks That Hit 52-Week Highs On Friday
Friday's morning session saw 60 companies set new 52-week highs.
Benzinga · 05/08 14:32
Why Aptevo Therapeutics Is Trading Higher Today
Aptevo Therapeutics Inc (NASDAQ: APVO) shares are trading higher on Tuesday, after the company announced it regained compliance with the NASDAQ listing requirements.
Benzinga · 04/14 17:16
Aptevo Therapeutics Regains Compliance With Nasdaq Listing Requirements
ACCESSWIRE · 04/14 14:00
Aptevo Therapeutics EPS beats by $0.04, misses on revenue
seekingalpha · 03/25 18:10
Aptevo Therapeutics Reports 2019 Financial Results and Provides Business Update
ACCESSWIRE · 03/25 14:00
Aptevo Therapeutics Provides Update On Ongoing APVO436 Phase 1 Clinical Trial
ACCESSWIRE · 03/16 14:00
Aptevo Therapeutics Offers Update On Ongoing APVO436 Trial: Says Is Advancing On Schedule, Dosing In Cohort 6 To Begin Shortly
Benzinga · 03/16 13:07
Aptevo Therapeutics Sells IXINITY Hemophilia B Therapy for Estimated Proceeds in Excess of $100 Million
ACCESSWIRE · 02/28 14:05
Medexus Expands its US Product Portfolio by Acquiring the Hematology Asset IXINITY®
GlobeNewswire · 02/28 13:59
The Daily Biotech Pulse: Sangamo In Genome-Editing Therapy Deal With Biogen, FDA Nod For Biohaven, Passage Bio IPO
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 27)
Benzinga · 02/28 12:28
The Daily Biotech Pulse: Epizyme's Tazemetostat sNDA Accepted For Priority Review, Eisai To Withdraw Weight Loss Drug, Sol-Gel Prices Offering
The following is a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs Feb. 13.)
Benzinga · 02/14 13:23
The Daily Biotech Pulse: Deciphera Cancer Drug Gets Priority Review, Fast Track Designation For Soligenix, Revolution Medicines IPO
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 12)
Benzinga · 02/13 13:05
Aptevo Therapeutics Doses First Patient in IXINITY Clinical Trial for Potential Pediatric Label Expansion
ACCESSWIRE · 01/30 14:00
Aptevo Therapeutics' APVO436 Selected For Inclusion In The Leukemia & Lymphoma Society's Groundbreaking BEAT AML(R) Master Clinical Trial
ACCESSWIRE · 01/13 13:00
Aptevo Therapeutics Inc. (APVO): Are Hedge Funds Right About This Stock?
Insider Monkey · 12/19/2019 20:50